SXTC icon

China SXT Pharmaceuticals

9 hedge funds and large institutions have $769K invested in China SXT Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$546K 2,228,517 +27,751 +1%
HF
2
HRT Financial
New York
$80K 328,435 +243,562 +287%
Renaissance Technologies
3
Renaissance Technologies
New York
$75K 304,674 -624,734 -67%
UBS Group
4
UBS Group
Switzerland
$33K 136,125 +11,355 +9%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$14K 56,253 -951,293 -94%
ECM
6
ExodusPoint Capital Management
New York
$11K 45,052 +45,052 New
VF
7
Virtu Financial
New York
$5K 21,377 +21,377 New
BWA
8
Beam Wealth Advisors
Louisiana
$4K 17,000
HI
9
Hudock Inc
Pennsylvania
$1K 5,000 +5,000 New
TSS
10
Two Sigma Securities
New York
-19,419 Closed
Citadel Advisors
11
Citadel Advisors
Florida
-12,513 Closed
CFGS
12
Concourse Financial Group Securities
Alabama